Cargando…

The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation

High-risk human papillomaviruses (hrHPVs) infect keratinocytes and successfully evade host immunity despite the fact that keratinocytes are well equipped to respond to innate and adaptive immune signals. Using non-infected and freshly established or persistent hrHPV-infected keratinocytes we show th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tummers, Bart, Goedemans, Renske, Pelascini, Laetitia P. L., Jordanova, Ekaterina S., van Esch, Edith M. G., Meyers, Craig, Melief, Cornelis J. M., Boer, Judith M., van der Burg, Sjoerd H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Pub. Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382698/ https://www.ncbi.nlm.nih.gov/pubmed/26055519 http://dx.doi.org/10.1038/ncomms7537

Ejemplares similares

Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFNγ- and TNFα-Mediated Antiproliferative Effects and Necroptosis
por: Ma, Wenbo, et al.
Publicado: (2016)

CD40-Mediated Amplification of Local Immunity by Epithelial Cells Is Impaired by HPV
por: Tummers, Bart, et al.
Publicado: (2014)

High-Risk Human Papillomavirus Targets Crossroads in Immune Signaling
por: Tummers, Bart, et al.
Publicado: (2015)

Human Papillomavirus (HPV) Upregulates the Cellular Deubiquitinase UCHL1 to Suppress the Keratinocyte's Innate Immune Response
por: Karim, Rezaul, et al.
Publicado: (2013)

Human Papillomavirus Deregulates the Response of a Cellular Network Comprising of Chemotactic and Proinflammatory Genes
por: Karim, Rezaul, et al.
Publicado: (2011)

A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency
por: Punt, Simone, et al.
Publicado: (2016)

Synergy between chemotherapy and cancer vaccination
por: van der Sluis, Tetje C., et al.
Publicado: (2015)

TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients
por: Zom, Gijs G., et al.
Publicado: (2016)

A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer
por: Dijkgraaf, Eveline M., et al.
Publicado: (2015)

IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma
por: Melief, Sara M., et al.
Publicado: (2017)

Synergy of therapeutic vaccination against HPV16 oncogenic proteins and standard chemotherapeutics
por: Melief, Cornelis J, et al.
Publicado: (2014)

Spontaneous tumor rejection by cbl-b–deficient CD8(+) T cells
por: Loeser, Stefanie, et al.
Publicado: (2007)

Molecular Mimicry of Human Cytochrome P450 by Hepatitis C Virus at the Level of Cytotoxic T Cell Recognition
por: Kammer, Andreas R., et al.
Publicado: (1999)

Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer
por: van Poelgeest, Mariëtte I. E., et al.
Publicado: (2016)

A pre‐existing coordinated inflammatory microenvironment is associated with complete response of vulvar high‐grade squamous intraepithelial lesions to different forms of immunotherapy
por: Abdulrahman, Ziena, et al.
Publicado: (2020)

The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools
por: Singh, Satwinder Kaur, et al.
Publicado: (2012)

Delayed vaccine-induced CD8(+) T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradication
por: van der Sluis, Tetje C, et al.
Publicado: (2023)

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
por: van Poelgeest, Mariette I E, et al.
Publicado: (2013)

Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma
por: de Lange, Mark J., et al.
Publicado: (2015)

Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative
por: Koskimaa, Hanna-Mari, et al.
Publicado: (2015)

Special Review: The future of Immunotherapy
por: Melief, Cornelis J M
Publicado: (2020)

Two types of biomarker-dependent chemo-immunotherapy for pancreatic cancer?
por: Melief, Cornelis J.M.
Publicado: (2022)

The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study
por: Singh, Satwinder Kaur, et al.
Publicado: (2012)

CD163(+) cytokine-producing cDC2 stimulate intratumoral type 1 T cell responses in HPV16-induced oropharyngeal cancer
por: Santegoets, Saskia J, et al.
Publicado: (2020)

Immunotherapy of Human Papilloma Virus Induced Disease
por: van der Burg, Sjoerd H
Publicado: (2012)

Human immunodeficiency virus and human papilloma virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful
por: van der Burg, Sjoerd H, et al.
Publicado: (2009)

Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination
por: Abdulrahman, Ziena, et al.
Publicado: (2020)

The presence of human papillomavirus (HPV) in placenta and/or cord blood might result in Th2 polarization
por: Koskimaa, H.-M., et al.
Publicado: (2017)

Possible different genotypes for human papillomavirus vaccination in lower middle-income countries towards cervical cancer elimination in 2030: a cross-sectional study
por: Utami, Tofan Widya, et al.
Publicado: (2022)

Highly individual methylation patterns of alternative glucocorticoid receptor promoters suggest individualized epigenetic regulatory mechanisms
por: Turner, Jonathan D., et al.
Publicado: (2008)

The association between viral load and concurrent human papillomavirus infection at the genital and anal sites of young women and the impact of vaccination
por: van Eer, Kahren, et al.
Publicado: (2021)

The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy
por: Verdegaal, Els M. E., et al.
Publicado: (2017)

Papillomavirus Infectious Pathways: A Comparison of Systems
por: Biryukov, Jennifer, et al.
Publicado: (2015)

Human papillomavirus 16 E2-, E6- and E7-specific T-cell responses in children and their mothers who developed incident cervical intraepithelial neoplasia during a 14-year follow-up of the Finnish Family HPV cohort
por: Koskimaa, Hanna-Mari, et al.
Publicado: (2014)

Triage of human papillomavirus infected women by methylation analysis in first-void urine
por: Van Keer, Severien, et al.
Publicado: (2021)

Molecular heterogeneity in human papillomavirus‐dependent and ‐independent vulvar carcinogenesis
por: Swarts, Dorian R. A., et al.
Publicado: (2018)

Identification and manipulation of tumor associated macrophages in human cancers
por: Heusinkveld, Moniek, et al.
Publicado: (2011)

A framework for T cell assays
por: Britten, Cedrik M., et al.
Publicado: (2015)

FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma
por: Punt, Simone, et al.
Publicado: (2015)

Novel insights into the HLA class I immunopeptidome and T-cell immunosurveillance
por: Melief, Cornelis J. M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vk841ug4i1i4mb7jm252ohtuae